Skip to content
MedsAcross

Medicine

Clopidogrel 75 mg tablet

Clopidogrel · Oral
Available on requestPrescription onlyUS FDAGeneric name

Clopidogrel 75 mg tablet is a generic prescription medicine for oral use, made by 31 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C(77°F), excursions permitted from 15°C to 30°C (59°F to 86°F)…

Key facts

Active ingredient (INN)
Clopidogrel
Brand
Sold under the generic name
Strength
75 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 1000 tablets, 30 tablets and 141 more
Manufacturers
Aurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaTorrent PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaNovadoz PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaAscend LaboratoriesIndiaCamber PharmaceuticalsIndiaAmneal Pharmaceuticals31 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C(77°F), excursions permitted from 15°C to 30°C (59°F to 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B01AC03 Clopidogrel
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 May 2012
Identifiers
RxCUI 309362, 749196DailyMed set ID d49362ae-f78a-47d8-ac14-8262d621fcaa, ae07b785-b522-41c6-b27c-24c4d5cd814d, 02f0eaf8-0fc2-425d-8259-cef00156e25d +37NDC 71610-527, 13668-141, 50090-5781 +37Application ANDA076274, ANDA090844, ANDA202928 +11

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 31 labelers. The register lists 144 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
500 tablet, film coated in 1 bottle43598-121-05Dr. Reddy's LaboratoriesIndia15 April 2025
1000 tablet, film coated in 1 bottle43598-121-10Dr. Reddy's LaboratoriesIndia15 April 2025
30 tablet, film coated in 1 bottle43598-121-30Dr. Reddy's LaboratoriesIndia15 April 2025
90 tablet, film coated in 1 bottle43598-121-90Dr. Reddy's LaboratoriesIndia15 April 2025
500 tablet, film coated in 1 bottle55111-196-05Dr. Reddy's LaboratoriesIndia17 May 2012
90 tablet, film coated in 1 bottle55111-196-90Dr. Reddy's LaboratoriesIndia17 May 2012
500 tablet in 1 bottle67877-276-05Ascend LaboratoriesIndia16 May 2024
30 tablet in 1 bottle67877-276-30Ascend LaboratoriesIndia16 May 2024
90 tablet in 1 bottle67877-276-90Ascend LaboratoriesIndia16 May 2024
100 tablet, film coated in 1 bottle65862-357-01Aurobindo PharmaIndia17 May 2012
500 tablet, film coated in 1 bottle65862-357-05Aurobindo PharmaIndia17 May 2012
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack65862-357-10Aurobindo PharmaIndia17 May 2012
30 tablet, film coated in 1 bottle65862-357-30Aurobindo PharmaIndia17 May 2012
90 tablet, film coated in 1 bottle65862-357-90Aurobindo PharmaIndia17 May 2012
1000 tablet, film coated in 1 bottle65862-357-99Aurobindo PharmaIndia17 May 2012
500 tablet in 1 bottle31722-758-05Camber PharmaceuticalsIndia4 August 2023
30 tablet in 1 bottle31722-758-30Camber PharmaceuticalsIndia4 August 2023
90 tablet in 1 bottle31722-758-90Camber PharmaceuticalsIndia4 August 2023
30 tablet in 1 bottle33342-060-07Macleods PharmaceuticalsIndia16 October 2012
90 tablet in 1 bottle33342-060-10Macleods PharmaceuticalsIndia11 September 2014
100 tablet in 1 box, unit-dose33342-060-12Macleods PharmaceuticalsIndia16 October 2012
500 tablet in 1 bottle33342-060-15Macleods PharmaceuticalsIndia16 October 2012
1000 tablet in 1 bottle33342-060-44Macleods PharmaceuticalsIndia12 May 2023
1000 tablet, film coated in 1 bottle72205-199-01Novadoz PharmaceuticalsIndia12 November 2025
500 tablet, film coated in 1 bottle72205-199-05Novadoz PharmaceuticalsIndia22 November 2024
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack72205-199-06Novadoz PharmaceuticalsIndia22 November 2024
30 tablet, film coated in 1 bottle72205-199-30Novadoz PharmaceuticalsIndia22 November 2024
90 tablet, film coated in 1 bottle72205-199-90Novadoz PharmaceuticalsIndia22 November 2024
500 tablet, film coated in 1 bottle47335-894-13Sun Pharmaceutical IndustriesIndia18 May 2012
1000 tablet, film coated in 1 bottle47335-894-18Sun Pharmaceutical IndustriesIndia18 May 2012
90 tablet, film coated in 1 bottle47335-894-19Sun Pharmaceutical IndustriesIndia18 May 2012
90 tablet, film coated in 1 bottle47335-894-81Sun Pharmaceutical IndustriesIndia18 May 2012
30 tablet, film coated in 1 bottle47335-894-83Sun Pharmaceutical IndustriesIndia18 May 2012
100 tablet, film coated in 1 bottle13668-141-01Torrent PharmaceuticalsIndia17 May 2012
500 tablet, film coated in 1 bottle13668-141-05Torrent PharmaceuticalsIndia17 May 2012
1000 tablet, film coated in 1 bottle13668-141-10Torrent PharmaceuticalsIndia17 May 2012
30 tablet, film coated in 1 bottle13668-141-30Torrent PharmaceuticalsIndia17 May 2012
3100 tablet, film coated in 1 bottle13668-141-44Torrent PharmaceuticalsIndia17 May 2012
90 tablet, film coated in 1 bottle13668-141-90Torrent PharmaceuticalsIndia17 May 2012
30 tablet in 1 bottle65162-414-03Amneal Pharmaceuticals30 September 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 17 November 1997Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Clopidogrel 75 mg tablet.

Compare 1

Other strengths and forms of Clopidogrel

Clinical summary

Clopidogrel is a P2Y12 platelet inhibitor indicated for acute coronary syndrome – For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), among other approved uses. MedsAcross supplies Clopidogrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clopidogrel

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Clopidogrel 75 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.